Obsessive-Compulsive Disorder Clinical Trial
Official title:
Cultural Adaptation and Evaluation of Traditional Islamically Integrated Psychotherapy for Muslim With OCD in Pakistan: A Mixed-Method Study.
Verified date | March 2024 |
Source | International Islamic University Malaysia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The current study aims to determine the effectiveness of the first culturally adapted Traditional Islamically Integrated Psychotherapy (TIIP) for Muslims with OCD in Pakistan along with the module effectiveness in reducing OCD symptoms with comorbidities like anxiety, depression, stress, thought control, thought-action fusion, and enhancing the spiritual quality of life of participants.
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | November 30, 2024 |
Est. primary completion date | October 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 40 Years |
Eligibility | Inclusion Criteria: - The client diagnosed with OCD according to DSM-5-TR. - The minimum score on Y-BOCS is 08 (i.e., indicating moderate level of symptoms) - The age range is from 18 to 40 years - The client has a minimum of eight years of formal education Exclusion Criteria: - The client is having a comorbid diagnosis of severe psychiatric illness (e.g., psychotic disorders, personality disorder, substance use disorder, neurocognitive disorder) - The client is having a comorbidity of chronic physical illness - The client refused to sign the informed consent form, - The client has experience undergoing manualized faith-based CBT |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
International Islamic University Malaysia | Foundation University Islamabad |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Yale Brown Obsessive Compulsive Scale | Yale Brown Obsessive Compulsive is a 10-item self-report scale developed to assess the severity of both obsession and compulsion.
Minimum score is 0 and maximum score is 40. The higher the scores mean the worst outcome. Cut-off Scores: 0-7 (sub-clinical) 8-15 (Mild) 16-23 (Moderate) 24-31 (severe) 32-40 (Extrerme) |
8 weeks | |
Secondary | Depression, Stress, Anxiety | Depression, Stress, Anxiety is measured through scale
Minimum score is 0 and maximum score is 42. The higher the scores mean the worst outcome. Cut-off scores for each subscales. Stress: 0-10 (normal) 11-18 (mild) 19-26 (moderate) 27-34 (severe) 35-42 (Extremely severe) Anxiety: 0-6 (normal) 7-9 (mild) 10-14 (moderate) 15-19 (severe) 20-42 (Extremely severe) Depression: 0-9 (normal) 10-12 (mild) 13-20 (moderate) 21-27 (severe) 28-42 (Extremely Severe) |
8 Weeks. | |
Secondary | Thought Action Fusion | Thought Action Fusion is measured with the help of Thought Action Fusion Scale
Minimum score is 0 and maximum score is 76. The higher the scores mean the worst outcome. |
8 weeks | |
Secondary | Thought Control | Thought Control is measured with the help of Thought Control Questionnaire
Minimum score is 30 and maximum score is 120. The higher the scores mean the worst outcome. |
8 weeks | |
Secondary | Spiritual Quality | Spiritual Quality is measured with the help of World Health Organization Quality of Life Spirituality, Religiousness and Personal Beliefs Scale
Minimum score is 9 and maximum score is 45. The higher the scores mean the worst outcome. |
8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04934007 -
Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder
|
N/A | |
Recruiting |
NCT04071990 -
Family Involvement in CBGT of OCD: a Randomized Controlled Trial
|
N/A | |
Completed |
NCT02541968 -
Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Recruiting |
NCT05391503 -
Light Therapy for Obsessive-compulsive Disorder (OCD)
|
N/A | |
Recruiting |
NCT04539951 -
Pragmatic Trial of Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT03416504 -
Methods for Managing Intrusive Thoughts
|
N/A | |
Not yet recruiting |
NCT06029738 -
Effect on Obsessive-Compulsive Beliefs and Symptoms of MCT-OCD
|
N/A | |
Recruiting |
NCT02844049 -
European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS
|
N/A | |
Terminated |
NCT02909660 -
What Are You Looking for? Psychometric and Experimental Analyses of Reassurance Seeking in Obsessive-compulsive Disorder
|
N/A | |
Completed |
NCT02911324 -
Cannabinoid Medication for Adults With OCD
|
Phase 1/Phase 2 | |
Completed |
NCT02217995 -
Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients
|
N/A | |
Terminated |
NCT02234011 -
A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder
|
Phase 2 | |
Withdrawn |
NCT01953042 -
Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders
|
N/A | |
Completed |
NCT02655926 -
Deep Brain Stimulation for Severe Obsessive Compulsive Disorder
|
N/A | |
Completed |
NCT04919785 -
Deep Brain Stimulation in Severe Obsessive-compulsive Disorder
|
N/A | |
Completed |
NCT00742664 -
Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project
|
Phase 1/Phase 2 | |
Terminated |
NCT00758966 -
Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder
|
Phase 2 | |
Completed |
NCT00523718 -
Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT00074815 -
Treatment of Obsessive Compulsive Disorder in Children
|
Phase 3 |